In the last trading session, 1.27 million 4D Molecular Therapeutics Inc (NASDAQ:FDMT) shares changed hands as the company’s beta touched 2.85. With the company’s per share price at $4.47 changed hands at -$0.32 or -6.68% during last session, the market valuation stood at $207.08M. FDMT’s last price was a discount, traded about -547.2% off its 52-week high of $28.93. The share price had its 52-week low at $2.23, which suggests the last value was 50.11% up since then.
Analysts gave the 4D Molecular Therapeutics Inc (FDMT) stock a consensus recommendation rating of Buy, calculated at a mean rating of 1.82. If we narrow down to specifics, the data shows that 0 out of 4 analysts rate the stock as a Sell, with a further 0 assigning it an Overweight rating. Of the remaining, 0 recommended FDMT as a Hold, 4 felt it is a Buy and 0 rated the stock as Underweight.
4D Molecular Therapeutics Inc (NASDAQ:FDMT) trade information
Instantly FDMT was in red as seen at the end of in last trading. With action 15.50%, the performance over the past five days has been green. The company’s shares are showing year-to-date downside of -19.75%, with the 5-day performance at 15.50% in the green. However, in the 30-day time frame, 4D Molecular Therapeutics Inc (NASDAQ:FDMT) is 45.13% up.
The consensus price target for the stock as assigned by Wall Street analysts is 6, meaning bulls need an upside of 25.5% from its current market value. According to analyst projections, FDMT’s forecast low is 6 with 6 as the target high. To hit the forecast high, the stock’s price needs a -34.23% plunge from its current level, while the stock would need to soar -34.23% for it to hit the projected low.
4D Molecular Therapeutics Inc (FDMT) estimates and forecasts
Looking at the company’s year-on-year earnings, data shows that the past 5-year has an earnings growth rate of -9.89%. The 2025 estimates are for 4D Molecular Therapeutics Inc earnings to decrease by -19.97%, but the outlook for the next 5-year period is at -11.31% per year.
4D Molecular Therapeutics Inc (NASDAQ:FDMT)’s Major holders
BLACKROCK INC. holds the second largest percentage of outstanding shares, with 8.8579% or 4.9 million shares worth $102.79 million as of 2024-06-30.
Among Mutual Funds, the top two as of Mar 31, 2025 were VANGUARD INDEX FUNDS-Vanguard Total Stock Market Index Fund and iShares Trust-iShares Russell 2000 ETF. With 1.54 shares estimated at $6.87 million under it, the former controlled 3.32% of total outstanding shares. On the other hand, iShares Trust-iShares Russell 2000 ETF held about 2.47% of the shares, roughly 1.14 shares worth around $5.11 million.
